Gelonghui, Feb. 8, 丨 Huisheng Biotech (300871.SZ) announced that on February 7, 2024, the company received a “Securities Transfer Registration Confirmation” issued by the Shenzhen branch of China Securities Registration and Settlement Co., Ltd., and 1,635,450 shares of the company's shares held by the “Wuhan Huisheng Biotechnology Co., Ltd. Repurchase Special Securities Account” were transferred to “Wuhan Huisheng Biotechnology Co., Ltd. - 2023 Employee Stock Ownership Plan” on February 6, 2024. The number of shares transferred accounts for 0.99% of the company's total share capital. 10.00 yuan/share. The total number of shares held by all active employee stock ownership plans of the company shall not exceed 10% of the total share capital of the company, and the total number of shares corresponding to the share of the shareholding plan held by a single employee shall not exceed 1% of the total share capital of the company.
According to the company's “Employee Stock Ownership Plan (Draft)”, the term of the employee's shareholding plan is 48 months, calculated from the date the company announces the last transfer of the underlying stock to the employee's shareholding plan. The target shares obtained under the current employee stock ownership plan through non-transactional transfers and other methods permitted by laws and regulations will be unlocked in 3 installments from the date the company announced the completion of the transfer of the underlying stock to the employee's shareholding plan. The unlocking ratio for each instalment was 40%, 30%, and 30%, respectively.